From The Stage

[EPISODE 2] Dr. Marianne Fjording Talks Biomarkers, CROs, and Tomatoes!

Posted by Ad Leverage / /

In today’s episode, Dr. Chad Briscoe sits down with guest scientist and biomarker expert, Dr. Marianne Fjording (Scientific Officer, BioAgilytix). Marianne and Chad discuss her expertise in biomarkers and EU bioanalysis- including how Denmark became a scientific hub and what fit-for-purpose really means. They also dive into Marianne’s jump from pharma to CRO, a family trip gone wrong, and how she ended up with over 100 varieties of tomatoes during the COVID quarantine.

[EPISODE 1] Dr. Jim McNally Talks Gene Therapy, Superheroes and Celery!

Posted by Ad Leverage / /

Welcome to episode one of the Molecular Moments podcast! On this first episode, Dr. Chad Briscoe is joined by his guest, Ph.D scientist, Dr. Jim McNally, and they get down to business as the two explore the various nuances in the outstanding work of McNally, how his career in bioanalysis became personal in an unexpected way, and what type of gene therapy it would take to create the next Superman or Hulk! They also discuss: How bioanalysis has evolved within the gene therapy space and how it has the ability…

BioAgilytix Bioanalytical Lab Welcomes the Phadia 200 to Its Hamburg Laboratory

Posted by BioAgilytix / /

HAMBURG, Germany — BioAgilytix is thrilled to announce the addition of a new diagnostics tool to their growing list of cutting-edge bioanalysis instruments. With the help of this innovative instrument, BioAgilytix will be able to streamline their workflow with flexible, controlled testing that requires very little training to effectively operate. Mainly designed to aid in the diagnosis of allergic and autoimmune diseases, the Phadia 200 is an all-in-one solution for batch testing and is able to accurately process a wide variety of assays. Stefan Wolf, President of Immunodiagnostics at Thermo…

Governor Cooper Announces 878 New Jobs as BioAgilytix Chooses Durham for Major Expansion

Posted by Ad Leverage / /

Bioanalytical life science company to invest $61.5 million RALEIGH: BioAgilytix Labs, LLC, a leading life science testing company, will create 878 jobs and invest $61.5 million in Durham, Governor Roy Cooper announced today. The project marks a major expansion of the contract research organization’s operations in North Carolina’s Research Triangle region. “North Carolina is a world-class location for companies that lead in research and development to treat and prevent diseases like the coronavirus,” said Governor Cooper. “Companies like BioAgilytix expand here because they know North Carolina can provide the skilled…

TBJ Reveals the 2020 Fast 50 Award Winners

Posted by Ad Leverage / /

BioAgilytix has recently been awarded the 2020 Fast 50 Award by Triangle Business Journal as one of the fastest-growing private companies within our region.